<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine whether adults diagnosed with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> from age 18 to 44 years more aggressively develop clinical complications after diagnosis than adults diagnosed at &gt;or=45 years of age </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We compared outcomes among 7844 adults in a health maintenance organization who were newly diagnosed with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> between 1996 and 1998 </plain></SENT>
<SENT sid="2" pm="."><plain>We abstracted clinical data from electronic medical, laboratory, and pharmacy records </plain></SENT>
<SENT sid="3" pm="."><plain>To adjust for length of follow-up and sex, we used proportional hazards models to compare incident complication rates through 2001 between <z:hpo ids='HP_0003674'>onset</z:hpo> groups (mean follow-up 3.9 years) </plain></SENT>
<SENT sid="4" pm="."><plain>To adjust for the increasing prevalence of macrovascular disease with advancing age, <z:hpo ids='HP_0003674'>onset</z:hpo> groups were matched by age and sex to control subjects without <z:mp ids='MP_0002055'>diabetes</z:mp> for macrovascular outcomes </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Adults with early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were 80% more likely to begin insulin therapy than those with usual-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (hazards ratio [HR] 1.8, 95% CI 1.5-2.0), despite a similar average time to requiring insulin ( approximately 2.2 years) </plain></SENT>
<SENT sid="6" pm="."><plain>Although the combined risk of microvascular complications did not differ overall, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> was more likely in early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than usual-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (HR 1.2, 95% CI 1.1-1.4) </plain></SENT>
<SENT sid="7" pm="."><plain>The hazard of any macrovascular complication in early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 diabetic patients compared with control subjects was twice as high in usual-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 diabetic patients compared with control subjects (HR 7.9 vs. 3.8, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001658'>Myocardial infarction</z:hpo> (MI) was the most common macrovascular complication, and the hazard of developing an MI in early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 diabetic patients was 14-fold higher than in control subjects (HR 14.0, 95% CI 6.2-31.4) </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, adults with usual-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had less than four times the risk of developing an MI compared with control subjects (HR 3.7, P &lt; 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> appears to be a more <z:e sem="disease" ids="C0001807" disease_type="Mental or Behavioral Dysfunction" abbrv="">aggressive disease</z:e> from a cardiovascular standpoint </plain></SENT>
<SENT sid="11" pm="."><plain>Although the absolute rate of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) is higher in older adults, young adults with early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have a much higher risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> relative to age-matched control subjects </plain></SENT>
</text></document>